First Time Loading...
W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 14 420 KRW -0.21% Market Closed
Updated: May 9, 2024

Wall Street
Price Targets

Price Targets Summary
Whanin Pharm Co Ltd

Wall Street analysts forecast Whanin Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Whanin Pharm Co Ltd is 21 420 KRW with a low forecast of 21 210 KRW and a high forecast of 22 050 KRW.

Lowest
Price Target
21 210 KRW
47% Upside
Average
Price Target
21 420 KRW
49% Upside
Highest
Price Target
22 050 KRW
53% Upside
Whanin Pharm Co Ltd Competitors:
Price Targets
OCUL
Ocular Therapeutix Inc
175% Upside
ORMP
Oramed Pharmaceuticals Inc
78% Upside
NECLIFE
Nectar Lifesciences Ltd
21% Upside
4502
Takeda Pharmaceutical Co Ltd
21% Upside
AGY
Allergy Therapeutics PLC
388% Upside
VRNO
Verano Holdings Corp
149% Upside
SEQUENT
SeQuent Scientific Ltd
14% Upside
TUB
Financiere de Tubize SA
46% Upside

Revenue
Forecast

Revenue Estimate
Whanin Pharm Co Ltd

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 9%.

6%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Whanin Pharm Co Ltd

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's operating income is 2%. The projected CAGR for the next 2 years is 9%.

2%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Whanin Pharm Co Ltd

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's net income is 5%. The projected CAGR for the next 2 years is -8%.

5%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
7%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Whanin Pharm Co Ltd's stock price target?
Price Target
21 420 KRW

According to Wall Street analysts, the average 1-year price target for Whanin Pharm Co Ltd is 21 420 KRW with a low forecast of 21 210 KRW and a high forecast of 22 050 KRW.

What is Whanin Pharm Co Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 9%.

What is Whanin Pharm Co Ltd's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's operating income is 2%. The projected CAGR for the next 2 years is 9%.

What is Whanin Pharm Co Ltd's Net Income forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for Whanin Pharm Co Ltd's net income is 5%. The projected CAGR for the next 2 years is -8%.